OPTICERA - Identification of factors allowing a therapeutic anemia management optimization in CKD patients treated with C.E.R.A.

Head :
Roche Medical data center

Last update : 11/08/2021 | Version : 1 | ID : 74090

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

French version
send
Send
General
Identification
Detailed name Identification of factors allowing a therapeutic anemia management optimization in CKD patients treated with C.E.R.A.
Sign or acronym OPTICERA
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation ML39300
General Aspects
Medical area Urology, andrology and nephrology
Study in connection with Covid-19 No
Pathology (details) Anemia in Chronic Kidney Disease
Health determinants Medicine
Keywords Méthoxy-polyéthylène glycol-époétine bêta
Scientific investigator(s) (Contact)
Name of the director Roche Medical data center
Address 4 cours de l'Ile Seguin - 92100 Boulognne-Billancourt
Email data_sharing.france@roche.com
Organization Roche SAS
Collaborations
Participation in projects, networks and consortia No
Funding
Funding status Private
Governance of the database
Sponsor(s) or organisation(s) responsible Roche SAS
Organisation status Private
Presence of scientific or steering committees Yes
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health care professionals
Database recruitment is is made on the basis of: Medication(s) taken
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Primary Objective: To identify the potential factors of optimizing the therapeutic management of renal anemia with C.E.R.A.
Secondary Objectives:
- Analysis of the therapeutic response to C.E.R.A., according to 4 definitions (reach or maintenance of the Hb concentration within the therapeutic target range of [10-12] g/dL, limitation of Hb variability at +/- 1 g/dL from the baseline value, both above criteria, or at least one of the above criteria, after a 3-month treatment period)
- Description of patient and disease characteristics at first C.E.R.A. injection
- Description of the evolution of CKD management (physical examination, laboratory parameters including Hb values and renal function, prior and ongoing concomitant treatments for anemia, as well as concomitant diseases and treatments) under C.E.R.A. treatment
- Search for any associations/correlations between variables and detection of particular profiles.
Inclusion criteria Inclusion criteria:
- CKD patients having started C.E.R.A. treatment at inclusion
- With at least one Hb value within the 3-month period prior to the first C.E.R.A. injection
- With no participation in an interventional study
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology D63 - Anaemia in chronic diseases classified elsewhere
Gender Male
Woman
Geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2009
Date of last collection (YYYY or MM/YYYY) 2015
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 2984
Data
Database activity Data collection completed
Type of data collected Clinical data
Clinical data (detail) Medical registration
Details of collected clinical data Pooling of 5 non-interventional studies with Mircera® (OCEANE / HORTENSIA / COMETE / PERCEPOLIS / MIRIADE). Type of data collected : demographics, comorbidities, CKD history, prior treatments for anemia, laboratory data, first C.E.R.A. injection, other treatments, vital signs, treatment for anemia, C.E.R.A. injections, other treatments, early withdrawal.
Presence of a biobank No
Procedures
Data collection method Pool of 5 non interventional databases
Classifications used CDISC like
Quality procedure(s) used GCP/GVP
Participant monitoring Yes
Monitoring procedures Monitoring by contact with the referring doctor
Followed pathology N18 - Chronic kidney disease
Links to administrative sources No
Promotion and access
Promotion
Access
Dedicated website https://www.roche.fr/fr/innovation-recherche-medicale/data-sharing-portail-d-information-partage-des-donnees.html
Presence of document that lists variables and coding procedures Yes
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here